美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
50242-040-86	50242-040	HUMAN PRESCRIPTION DRUG	XOLAIR	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20131220	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	150 mg/1.2mL	1 VIAL, SINGLE-USE in 1 CARTON (50242-040-86) / 1.2 mL in 1 VIAL, SINGLE-USE
50242-040-62	50242-040	HUMAN PRESCRIPTION DRUG	XOLAIR	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20030620	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	150 mg/1.2mL	1 VIAL, SINGLE-USE in 1 CARTON (50242-040-62) / 1.2 mL in 1 VIAL, SINGLE-USE
50242-214-03	50242-214	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	75 mg/.5mL	1 SYRINGE, GLASS in 1 CARTON (50242-214-03) / .5 mL in 1 SYRINGE, GLASS
50242-214-86	50242-214	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20180928	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	75 mg/.5mL	1 SYRINGE, GLASS in 1 CARTON (50242-214-86) / .5 mL in 1 SYRINGE, GLASS
50242-214-99	50242-214	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	75 mg/.5mL	1 SYRINGE, GLASS in 1 CARTON (50242-214-99) / .5 mL in 1 SYRINGE, GLASS
50242-215-01	50242-215	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20180928	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	150 mg/mL	1 SYRINGE, GLASS in 1 CARTON (50242-215-01) / 1 mL in 1 SYRINGE, GLASS
50242-215-03	50242-215	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	150 mg/mL	1 SYRINGE, GLASS in 1 CARTON (50242-215-03) / 1 mL in 1 SYRINGE, GLASS
50242-215-55	50242-215	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	150 mg/mL	1 SYRINGE, GLASS in 1 CARTON (50242-215-55) / 1 mL in 1 SYRINGE, GLASS
50242-215-83	50242-215	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	150 mg/mL	1 SYRINGE, GLASS in 1 CARTON (50242-215-83) / 1 mL in 1 SYRINGE, GLASS
50242-215-86	50242-215	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20180928	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	150 mg/mL	1 SYRINGE, GLASS in 1 CARTON (50242-215-86) / 1 mL in 1 SYRINGE, GLASS
50242-215-99	50242-215	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	150 mg/mL	1 SYRINGE, GLASS in 1 CARTON (50242-215-99) / 1 mL in 1 SYRINGE, GLASS
50242-214-01	50242-214	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20180928	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	75 mg/.5mL	1 SYRINGE, GLASS in 1 CARTON (50242-214-01) / .5 mL in 1 SYRINGE, GLASS
50242-214-55	50242-214	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	75 mg/.5mL	1 SYRINGE, GLASS in 1 CARTON (50242-214-55) / .5 mL in 1 SYRINGE, GLASS
50242-214-83	50242-214	HUMAN PRESCRIPTION DRUG	Xolair PFS	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	75 mg/.5mL	1 SYRINGE, GLASS in 1 CARTON (50242-214-83) / .5 mL in 1 SYRINGE, GLASS
50242-227-01	50242-227	HUMAN PRESCRIPTION DRUG	Xolair	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	300 mg/2mL	1 SYRINGE, GLASS in 1 CARTON (50242-227-01) / 2 mL in 1 SYRINGE, GLASS
50242-227-55	50242-227	HUMAN PRESCRIPTION DRUG	Xolair	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	300 mg/2mL	1 SYRINGE, GLASS in 1 CARTON (50242-227-55) / 2 mL in 1 SYRINGE, GLASS
50242-227-86	50242-227	HUMAN PRESCRIPTION DRUG	Xolair	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	300 mg/2mL	1 SYRINGE, GLASS in 1 CARTON (50242-227-86) / 2 mL in 1 SYRINGE, GLASS
50242-227-99	50242-227	HUMAN PRESCRIPTION DRUG	Xolair	omalizumab	INJECTION, SOLUTION	SUBCUTANEOUS	20230818	N/A	BLA	BLA103976	Genentech, Inc.	OMALIZUMAB	300 mg/2mL	1 SYRINGE, GLASS in 1 CARTON (50242-227-99) / 2 mL in 1 SYRINGE, GLASS